Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Proteopure
AddedFeb 15, 2024
UpdatedJun 18, 2026
Proteopure

Proteopure

Acquired

Proteopure Inc. offers advanced protein isolation solutions for biomarker and pharmacokinetics research in the US.

HQ
Pittsburgh, PA, US
Founded
2005
Overview
Compare
Fundraising
Employees

Proteopure Inc. offers advanced protein isolation solutions designed for biomarker and pharmacokinetics research. The company's innovative technology focuses on efficient protein binding and isolation, catering primarily to the research and pharmaceutical sectors in the United States.

Proteopure has made significant strides in enhancing the accuracy and efficiency of protein research, impacting both academic and commercial research fields. Their solutions have been adopted by leading institutions, contributing to advancements in biomarker discovery and drug development.

Proteopure - Similar Companies

Proteios Technology logo

Proteios Technology

proteios.com

Proteotech logo

Proteotech

BioNanoTech logo

BioNanoTech

bionanotech.co

Protein Foundry logo

Protein Foundry

proteinfoundry.com

NEO Proteomics logo

NEO Proteomics

neoproteomics.net

Impact Proteomics logo

Impact Proteomics

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

ProteoWise logo

ProteoWise

proteowise.com

AutekBio logo

AutekBio

Solus Biosystems logo

Solus Biosystems

Phasiq logo

Phasiq

PurSolutions logo

PurSolutions

puresoluble.com

Applied Proteomics logo

Applied Proteomics

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

ActivSignal logo

ActivSignal

activsignal.com

Proteopure - Quick Facts

Who are Proteopure's competitors?

Companies similar to Proteopure include Proteios Technology, Proteotech, BioNanoTech and Protein Foundry.

When was Proteopure founded?

Proteopure was founded in 2005.

Where is Proteopure's headquarters located?

Proteopure's headquarters is located in Pittsburgh, PA, US.

When was Proteopure's last funding round?

Proteopure's most recent funding round was for $100k (USD) in March 2006.

How much has Proteopure raised to-date?

As of Mar 21, 2006, Proteopure has raised a total of $100k (USD).

Proteopure - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Protein Isolation
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research